TAMAR D HOWSON Insider Trading $HEPA Hepion Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for TAMAR D HOWSON.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of TAMAR D HOWSON. TAMAR D HOWSON is SVP, Corp & Bus Development in BRISTOL MYERS SQUIBB CO ($BMY) and Director in OXIGENE INC ($OXGN) and Director in MEI Pharma, Inc. ($MEIP) and Director in IMMUNIC, INC. ($VTL) and Director in ORGANOVO HOLDINGS, INC. ($ONVO) and Director in Allergan plc ($AGN) and Director in ContraVir Pharmaceuticals, Inc. ($CTRV) and Director in Cue Biopharma, Inc. ($CUE).

TAMAR D HOWSON in Hepion Pharmaceuticals, Inc.

Trading Symbol: HEPA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TAMAR D HOWSON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 11 2017
$HEPA Market Capitalization: $85.72M
$HEPA Previous Close: $1.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of TAMAR D HOWSON in Hepion Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGN, BMY, CUE, HEPA, VTL, MEIP, MATN, ONVO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 11 2017CTRVContraVir Pharmace ...HOWSON TAMAR DDirectorOption ExerciseA1.6035,00056,00080,000

Page:   1